NRX Pharmaceuticals, Inc. - *W EXP 05/24/202 (NRXPW)

Historical Holders from Q2 2021 to Q3 2025

Type / Class
Equity / *W EXP 05/24/202
Symbol
NRXPW on Nasdaq
Price per share
$0.0756
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
3,063,963
Total reported value
$4,459,924
% of total 13F portfolios
0%
Share change
+3,001,720
Value change
+$4,454,975
Avg buy value change
+0%
Avg sell value change
0%
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, NRX Pharmaceuticals, Inc. - *W EXP 05/24/202 (NRXPW) has 4 institutional shareholders filing 13F forms. They hold 3,063,963 shares. .

Institutional Holders of NRX Pharmaceuticals, Inc. - *W EXP 05/24/202 (NRXPW) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 3,063,963 $4,459,924 +$4,454,975 7.56% 4
2025 Q2 62,243 $5,297 -$832 8.51% 3
2025 Q1 74,242 $6,159 +$32 7.12% 4
2024 Q4 73,597 $10,155 -$4,998 12.81% 5
2024 Q3 122,121 $5,934 +$70 4.5% 8
2024 Q2 118,731 $6,653 +$4,100 6.01% 6
2024 Q1 15,677 $2,838 -$598 18.79% 4
2023 Q4 23,081 $2,994 -$1,514 12.97% 3
2023 Q3 37,982 $3,041 +$1,668 8% 5
2023 Q2 17,144 $4,286 -$600 25.83% 2
2023 Q1 20,485 $3,687 +$604 18% 2
2022 Q4 17,129 $4,284 25.01% 1
2022 Q3 17,129 $5,000 -$2,000 29.19% 1
2022 Q2 32,807 $4,000 -$7,000 12.22% 2
2022 Q1 27,129 $24,000 -$33,315 88.79% 2
2021 Q4 59,856 $110,000 +$21,000 183.57% 3
2021 Q3 102,647 $486,000 -$250,751 473.65% 4
2021 Q2 160,817 $573,000 +$573,000 356.27% 3